![Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX]](https://cedclinic.com/wp-content/uploads/2026/06/ced-unsplash-ke6jYtwXDKA-1-150x150.jpg "Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX] 25")
Management of Opioid Withdrawal Syndrome and Opioid Dependence Treatment
Comments Off on Management of Opioid Withdrawal Syndrome and Opioid Dependence Treatment
March 26, 2026
Opioid withdrawal management is critical in cases involving synthetic opioid contamination such as protonitazene. This case report highlights the need for adjusted buprenorphine dosing. Effective opioid dependence treatment requires awareness of these…
Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
Comments Off on Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
March 8, 2026
Nitazene synthetic opioids such as N-pyrrolidino metonitazene and N-pyrrolidino protonitazene have been temporarily placed in Schedule I. These substances pose significant overdose risks and are emerging threats in illicit drug supplies. Clinicians…